Discover SOLACI Congress Satellite Symposia

SOLACI-SOCIME 2022

DISCOVER SOLACI CONGRESS’ SATELLITE SYMPOSIA

Together with the attractive agenda of life and edited cases, joint sessions, and international guests, we will be holding 3 key activities characteristic of SOLACI Congresses:

  • ProEducar Fellows course, 12th edition
  • Pediatrics and Congenital Cardiomyopathies Symposium
  • Nurses and Technicians Symposium

Discover the complete program for each of these activities. We look forward to seeing you at Expo Santa Fe, on August 4 to 6! 

SOLACI-SOCIME 2022

  MODULE 1: Preparing and planning an intervention
  MODULE 2: Structural Heart Disease
  LUNCH SESSION: “Talking to the Experts”. Educational Cases
  MODULE 3: Complex Coronary Intervention. Tips and Secrets of the Trade.
  MODULE 4: Non-Coronary Intervention
  Optional Test: 30 multiple choice questions

ProEducar Fellows Course Preliminary Program

SOLACI-SOCIME 2022

  Ductus Arteriosus
  LIVE CASE: Pulmonary Valve Implantation with a Melody Prosthesis
  Ventricular Septal Defects 
  Atrial Septal Defects
  How Do I Do It? Early Postoperative Intervention
  How Did I Solve Them? Complex Interventions
  Early Heart Intervention: Achievements, Challenges, and Expectations
  LIVE CASE FROM ARGENTINA
  Transcatheter Pulmonary Valve Replacement (our current status 20 years and one pandemic later)
  How Do I Do It? Obstructive Lesions: 5 Practical Tips
  How Did I Solve Them? Complex Interventions
  Complications in the Cath Lab: Avoiding them and Solving them

Pediatrics and Congenital Preliminary Program

SOLACI-SOCIME 2022

  MODULE 1: Coronary Interventionism
  MODULE 2: Coronary and Structural Pathology
  MODULE 3: Peripheral Disease
  MODULE 4: Bioimaging
  MODULE 5: Pediatric and Congenital Disease
  MODULE 6: Research and Education in Interventional Cardiology
  MODULE 7: Electrophisiology and Pacemakers
  MODULE 8: Interventional Neurology

Nurses and Technicians Preliminary Program

See the full Scientific Program

*Online registration through our website closed on July 22. Those who still want to join us will be able to register in person at Expo Santa Fe, Mexico City *as of August 3*.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

The SOLACI–CACI Technical Training in Hemodynamics and Interventional Cardioangiology is an academic program designed for the initial training and professional development of non-physician healthcare...

SOLACI Webinar for Nurses and Technicians | Cardiovascular Risk Factors in Women

Cardiovascular disease remains the leading cause of death in women. Do we truly understand its risk factors and warning signs? 📢 We invite you to...

SOLACI Session at Miami Valves 2026

Once again, the Latin American Society of Interventional Cardiology will be present at one of the most important congresses worldwide in the field, with...

Advanced Postgraduate Course in Hemodynamics and Interventional Cardiology – 2026 Edition

Registration is now open for the SOLACI–CACI Advanced Postgraduate Course in Hemodynamics and Interventional Cardiology – 2026 Edition. The program is intended for physicians with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...